![]() |
|
#1
|
|||
|
|||
|
(Reuters) – Teva Pharmaceutical Industries Ltd said Friday it hoped to win U.S. approval by late 2017 or early 2018 for its version of Mylan NV’s EpiPen device for treating severe allergic reactions, a move that would challenge the branded product’s overwhelming market dominance. ??????? ??????: Teva says hoping to launch EpiPen-like device by 2018 in U.S. || ??????: ahlam1399 || ??????: اسم منتداك
|
![]() |
|
|